Asia Healthcare Industry Digest
SEE OTHER BRANDS

The latest healthcare and wellness news from Asia and the Pacific

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on September 5, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Avania renforce son équipe de direction avec la nomination de quatre nouveaux dirigeants

Avania renforce son équipe de direction avec la nomination de quatre nouveaux dirigeants

BILTHOVEN, Pays-Bas et BOSTON, 05 sept. 2025 (GLOBE NEWSWIRE) -- Avania, le leader mondial du conseil et du développement clinique dans le secteur de la MedTech, a le plaisir d’annoncer la nomination stratégique de quatre dirigeants éminents. Alors que le …

Avania verstärkt Führungsteam mit der Ernennung von vier neuen Führungskräften

Avania verstärkt Führungsteam mit der Ernennung von vier neuen Führungskräften

BILTHOVEN, Niederlande und BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Avania, der weltweit führende Partner für Medizintechnikberatung und klinische Entwicklung, freut sich, die Ernennung von vier angesehenen Führungskräften in strategische …

메드테크 자문기업인 Avania, 4명의 신규 임원 임명으로 리더십 팀 강화

메드테크 자문기업인 Avania, 4명의 신규 임원 임명으로 리더십 팀 강화

네덜란드 빌트호벤 및 보스턴, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 선도적인 메드테크(MedTech) 자문 서비스와 임상 개발 파트너인 Avania가 4명의 저명한 임원을 전략적 리더십 자리에 임명한다고 발표했다. 메드테크 산업이 점점 복잡해지는 규제 환경과 기술 혁신을 헤쳐 나가는 가운데, 이번에 선임된 신규 임원들은 임상 연구, 규제 업무, 운영, 정보기술, 사업 개발 분야에서 수십 년에 걸친 경험을 결합해 Avania의 …

BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

BioStem Showcasing its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Fall Meeting

Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem’s proprietary allograft portfolio POMPANO BEACH, Fla., Sept. 05, 2025 (GLOBE …

Streamlined Cancer Tissue Analysis at KFSHRC Improves Patient Journey

Streamlined Cancer Tissue Analysis at KFSHRC Improves Patient Journey

RIYADH, Saudi Arabia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre applies Large-Format Tissue Processing to support a smoother, more reassuring diagnostic experience for patients undergoing cancer surgery. The …

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence …

Healthinsurance.org: 5 ways to prepare now for Marketplace open enrollment

Healthinsurance.org: 5 ways to prepare now for Marketplace open enrollment

Minneapolis, MN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- With Marketplace enrollees facing new documentation requirements and potentially large premium increases, now is the time to prepare for enrolling in 2026 coverage. According to healthinsurance.org, …

WellSpan announces changes to further enhance the safety and security of its facilities

WellSpan announces changes to further enhance the safety and security of its facilities

York, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- In support of its commitment to patient and team member safety, WellSpan Health today announced plans to further enhance security in its facilities, including increased weapons detection at entrances to its …

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

SAN DIEGO and SUZHOU, China, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted …

MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer

MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer

Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage …

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need  

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need  

~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~ ~Subgroups - including Black or African American adults, older adults, women, and …

Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)

Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to commence in H2 2025; Topline data anticipated in Q1 2026 Continued progress toward Phase 2 IND …

Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September

Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September

FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod …

Mobile Mining Equipment Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029

Mobile Mining Equipment Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029

The Business Research Company's Mobile Mining Equipment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 5, 2025 /⁨EINPresswire.com⁩/ -- What Is The Estimated Industry Size Of …

Modular Floating Dock Systems Market to Reach $4.74 Billion by 2029 with 8.3% CAGR

Modular Floating Dock Systems Market to Reach $4.74 Billion by 2029 with 8.3% CAGR

The Business Research Company's Modular Floating Dock System Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 5, 2025 /⁨EINPresswire.com⁩/ -- What Is The Modular Floating Dock …

Moisturizers Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029

Moisturizers Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029

The Business Research Company's Moisturizers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, UNITED KINGDOM, September 5, 2025 /⁨EINPresswire.com⁩/ -- How Much Is The Moisturizers Market Worth? In recent times, the …

Safety Shot Appoints BONK Core Contributor Mitchell Rudy (Nom) to Board of Directors

Safety Shot Appoints BONK Core Contributor Mitchell Rudy (Nom) to Board of Directors

Transition Marks Next Phase in Company’s Strategic Integration with the Digital Asset Ecosystem SCOTTSDALE, AZ, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT), a company evolving to bridge the gap between traditional public markets and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions